540 related articles for article (PubMed ID: 10407712)
21. Tolerability of a salmeterol xinafoate/fluticasone propionate hydrofluoroalkane metered-dose inhaler in adolescent and adult patients with persistent asthma: a 52-week, open-label, stratified, parallel-group, multicenter study.
Cowie RL; Boulet LP; Keith PK; Scott-Wilson CA; House KW; Dorinsky PM
Clin Ther; 2007 Jul; 29(7):1390-402. PubMed ID: 17825690
[TBL] [Abstract][Full Text] [Related]
22. Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: a 4-week, randomized, double-blind, placebo-controlled, parallel-group study.
Spencer TJ; Wilens TE; Biederman J; Weisler RH; Read SC; Pratt R
Clin Ther; 2006 Feb; 28(2):266-79. PubMed ID: 16678648
[TBL] [Abstract][Full Text] [Related]
23. Comparable morning versus evening administration of once-daily mometasone furoate dry powder inhaler.
Zetterström O; Dahl R; Lindqvist A; Olsson P
Respir Med; 2008 Oct; 102(10):1406-11. PubMed ID: 18640826
[TBL] [Abstract][Full Text] [Related]
24. Comparative study of budesonide inhalation suspension and montelukast in young children with mild persistent asthma.
Szefler SJ; Baker JW; Uryniak T; Goldman M; Silkoff PE
J Allergy Clin Immunol; 2007 Nov; 120(5):1043-50. PubMed ID: 17983871
[TBL] [Abstract][Full Text] [Related]
25. Efficacy and tolerability of budesonide Clickhaler and Turbuhaler in adult asthma.
Morice A; Das S; Ellis S;
J Asthma; 2005 Oct; 42(8):697-703. PubMed ID: 16266962
[TBL] [Abstract][Full Text] [Related]
26. Comparison of once-daily mometasone furoate versus once-daily budesonide in patients with moderate persistent asthma.
Corren J; Berkowitz R; Murray JJ; Prenner B
Int J Clin Pract; 2003 Sep; 57(7):567-72. PubMed ID: 14529054
[TBL] [Abstract][Full Text] [Related]
27. Efficacy and safety of formoterol Turbuhaler when added to inhaled corticosteroid treatment in children with asthma.
Zimmerman B; D'Urzo A; Bérubé D
Pediatr Pulmonol; 2004 Feb; 37(2):122-7. PubMed ID: 14730657
[TBL] [Abstract][Full Text] [Related]
28. Effects of treatment with mometasone furoate dry powder inhaler in children with persistent asthma.
Berger WE; Milgrom H; Chervinsky P; Noonan M; Weinstein SF; Lutsky BN; Staudinger H
Ann Allergy Asthma Immunol; 2006 Nov; 97(5):672-80. PubMed ID: 17165278
[TBL] [Abstract][Full Text] [Related]
29. Effects of budesonide inhalation suspension compared with cromolyn sodium nebulizer solution on health status and caregiver quality of life in childhood asthma.
Murphy KR; Fitzpatrick S; Cruz-Rivera M; Miller CJ; Parasuraman B
Pediatrics; 2003 Sep; 112(3 Pt 1):e212-9. PubMed ID: 12949315
[TBL] [Abstract][Full Text] [Related]
30. Budesonide delivered by Turbuhaler is effective in a dose-dependent fashion when used in the treatment of adult patients with chronic asthma.
Busse WW; Chervinsky P; Condemi J; Lumry WR; Petty TL; Rennard S; Townley RG
J Allergy Clin Immunol; 1998 Apr; 101(4 Pt 1):457-63. PubMed ID: 9564797
[TBL] [Abstract][Full Text] [Related]
31. Effect of disease duration on dose-response of inhaled budesonide in asthma.
Selroos O
Respir Med; 2008 Jul; 102(7):1065-72. PubMed ID: 18387797
[TBL] [Abstract][Full Text] [Related]
32. Once-daily budesonide inhalation suspension in infants and children < 4 and > or = 4 years of age with persistent asthma.
Scott MB; Ellis MH; Cruz-Rivera M; Fitzpatrick S; Smith JA
Ann Allergy Asthma Immunol; 2001 Dec; 87(6):488-95. PubMed ID: 11770696
[TBL] [Abstract][Full Text] [Related]
33. A controlled trial of twice daily triamcinolone oral inhaler in patients with mild-to-moderate asthma.
Ramsdell JW; Fish L; Graft D; Higgins N; Kavuru M; Pleskow W; Banerji D
Ann Allergy Asthma Immunol; 1998 May; 80(5):385-90. PubMed ID: 9609607
[TBL] [Abstract][Full Text] [Related]
34. Effects of budesonide inhalation suspension on hypothalamic-pituitary-adrenal-axis function in infants and young children with persistent asthma.
Irani AM; Cruz-Rivera M; Fitzpatrick S; Hoag J; Smith JA
Ann Allergy Asthma Immunol; 2002 Mar; 88(3):306-12. PubMed ID: 11926625
[TBL] [Abstract][Full Text] [Related]
35. Efficacy and safety of budesonide inhalation suspension (Pulmicort Respules) in young children with inhaled steroid-dependent, persistent asthma.
Shapiro G; Mendelson L; Kraemer MJ; Cruz-Rivera M; Walton-Bowen K; Smith JA
J Allergy Clin Immunol; 1998 Nov; 102(5):789-96. PubMed ID: 9819296
[TBL] [Abstract][Full Text] [Related]
36. Rapid induction of clinical response with a short-term high-dose starting schedule of budesonide nebulizing suspension in young children with recurrent wheezing episodes.
Volovitz B; Soferman R; Blau H; Nussinovitch M; Varsano I
J Allergy Clin Immunol; 1998 Apr; 101(4 Pt 1):464-9. PubMed ID: 9564798
[TBL] [Abstract][Full Text] [Related]
37. Development and validation of a nighttime sleep diary in asthmatic children.
Yoshihara S; Kanno N; Fukuda H; Yamada Y; Fukuda N; Tsuchiya T; Arisaka O
Pediatr Allergy Immunol; 2011 Nov; 22(7):667-70. PubMed ID: 21950678
[TBL] [Abstract][Full Text] [Related]
38. Efficacy of salmeterol xinafoate powder in children with chronic persistent asthma.
Weinstein SF; Pearlman DS; Bronsky EA; Byrne A; Arledge T; Liddle R; Stahl E
Ann Allergy Asthma Immunol; 1998 Jul; 81(1):51-8. PubMed ID: 9690573
[TBL] [Abstract][Full Text] [Related]
39. Once- vs twice-daily budesonide/formoterol in 6- to 15-year-old patients with stable asthma.
Eid NS; Noonan MJ; Chipps B; Parasuraman B; Miller CJ; O'Brien CD
Pediatrics; 2010 Sep; 126(3):e565-75. PubMed ID: 20713475
[TBL] [Abstract][Full Text] [Related]
40. [Budesonide in the treatment of mild asthma. A placebo-controlled multicenter study in general practice].
Damsbo N
Ugeskr Laeger; 1994 Oct; 156(43):6384-8. PubMed ID: 7810015
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
